There are currently no established biomarkers in HAIC treatment for HCC; in this context, PD‐1+CD8+ Tex‐int cells in C03_CD8T_DTHD1 showed promise as an effective biomarker for HAIC‐based treatment in HCC. Here, CD8A is linked to hepatocellular carcinoma.